Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aevis VictoriaXSWX:AEVS -0.38%56 EV-to-EBITDA is 24.58 as of Jul. 24, 2026, which is 9% below its 10-year median of 26.92. GuruFocus rates XSWX:AEVS with a GF Score™ of 56/100 and a GF Value™ of CHF16.87 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 507 Healthcare Providers & Services companies, Aevis Victoria ranks worse than 82.25% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Aevis Victoria's enterprise value is CHF2,066 Mil.
Aevis Victoria's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was CHF84 Mil. Therefore, Aevis Victoria's EV-to-EBITDA for today is 24.58.
The historical rank and industry rank for Aevis Victoria's EV-to-EBITDA or its related term are showing as below:
XSWX:AEVS'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.58 Med: 26.92 Max: 53.06
Current: 24.59
During the past 13 years, the highest EV-to-EBITDA of Aevis Victoria was 53.06. The lowest was 5.58. And the median was 26.92.
XSWX:AEVS's EV-to-EBITDA is ranked worse than 82.25% of 507
companies
in the Healthcare Providers & Services industry
Industry Median: 10.92
vs XSWX:AEVS: 24.59
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Aevis Victoria (XSWX:AEVS) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Aevis Victoria's PE Ratio (TTM) for today is calculated as:
Aevis Victoria's share price for today is CHF12.95.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aevis Victoria's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was CHF-0.240.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Aevis Victoria's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:AEVS vs HCA, THC, DVA: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Aevis Victoria's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aevis Victoria EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Aevis Victoria's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Aevis Victoria's EV-to-EBITDA falls into.
Aevis Victoria's current Enterprise Value is CHF2,066 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aevis Victoria's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was CHF84 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aevis Victoria (XSWX:AEVS) has a EV-to-EBITDA of 24.58 as of Jul. 24, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Aevis Victoria. This is near median its historical median of 26.92. Over the past decade, Aevis Victoria's EV-to-EBITDA has ranged from 5.58 to 53.06. According to the industry distribution chart, Aevis Victoria ranks #417 out of 507 companies in the Healthcare Providers & Services industry, placing it in the top 82.2%.
Is Aevis Victoria's EV-to-EBITDA too high?
Aevis Victoria's current EV-to-EBITDA of 24.58 is near median its 10-year median of 26.92. Over the past 10 years, this metric has ranged from a low of 5.58 to a high of 53.06. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.92. Aevis Victoria's value of 24.58 is 125.1% above this industry median. Based on the distribution chart, Aevis Victoria ranks #417 out of 507 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Aevis Victoria has a GF Score™ of 56/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aevis Victoria's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Aevis Victoria ranks #417 out of 507 companies for EV-to-EBITDA. This places Aevis Victoria in the lower half of its industry. The industry median EV-to-EBITDA is 10.92. Aevis Victoria's value of 24.58 is 125.1% above this benchmark. Historically, Aevis Victoria's own EV-to-EBITDA has ranged from 5.58 to 53.06 over the past decade. While the company's 10-year median is 26.92 vs. the industry median of 10.92, Aevis Victoria has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.92, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aevis Victoria's current EV-to-EBITDA of 24.58 is 125.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Aevis Victoria. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aevis Victoria's current EV-to-EBITDA is 24.58, which is near median its own 10-year median of 26.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aevis Victoria stock overvalued right now?
Based on GuruFocus' analysis, Aevis Victoria (XSWX:AEVS) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF16.87, compared to a current price of CHF12.95 — trading 23.2% below its estimated fair value. The current EV-to-EBITDA is 24.58, which is near median its 10-year median of 26.92 and 125.1% above the Healthcare Providers & Services industry median of 10.92. Aevis Victoria's overall GF Score™ is 56/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Aevis Victoria (XSWX:AEVS), the current EV-to-EBITDA is 24.58 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aevis Victoria (XSWX:AEVS) Overvalued in 2026?
Based on GuruFocus' analysis, Aevis Victoria stock appears to be undervalued.
The current stock price of CHF12.95 is trading 23.2% below its estimated GF Value™ of CHF16.87.
GuruFocus considers Aevis Victoria to be Modestly Undervalued.
Key valuation signals for XSWX:AEVS:
EV-to-EBITDA: 24.58 (near median its 10-year median of 26.92)
GF Value™: CHF16.87 vs. price of CHF12.95 (23.2% below fair value)
Industry Position: 125.1% above the Healthcare Providers & Services median (#417 of 507)
No single metric tells the full story. See the XSWX:AEVS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aevis Victoria SA is a medical care company with five segments: Healthcare, Hospitality, Real Estate, Others, and Corporate. The Healthcare business segment operates private hospitals and clinics. The Hospitality business segment owns and operates hospitals. The Real Estate segment operates healthcare-related real estate properties. The Others segment provides ambulance services, such as urgent patient transport and hospital transfers. The Corporate segment operates other miscellaneous business activities. It generates the vast majority of its revenue in Healthcare segment.
56GF Score
Get the complete analysis for XSWX:AEVS
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:AEVS has been successfully added to your 
